… the structure of GSK-3, the regulation of GSK-3 activity, and … of NMDA receptor-mediated
signaling by ketamine evoked … apparent that GSK-3 is a promising therapeutic target due to its …

… therapeutic targets of mood stabilizing drugs including: the glycogen synthase kinase-3 (GSK-3…
Ketamine binding to NMDA receptor was found to increase extracellular glutamate levels …

… The goal of the article is to contribute to better understanding and treatment of TRD, which
… kinase 3 (GSK-3) and AMPA receptors in the antidepressant effects of ketamine are also …

… main goal of the current depression research is to develop faster-… and enhances overall
memory and cognitive performance, … GSK-3 is one of the main regulators of neuronal survival, …

… synthase kinase-3 (GSK-3, a direct target of lithium) and histone … -affinity NMDA antagonists
such as ketamine may have … the AMPA receptor potentiator LY451646 increased progenitor …

… (AMPA) and the mammalian target of rapamycin by ketamine … combine ketamine with lithium
(which suppresses GSK 3 as … and should not obstruct the performance of important human …

… Increased synaptic glutamate levels and inhibition of NMDA by ketamine can lead to increased
influx of sodium via AMPA … kinase3 (GSK-3) leading to increased BDNF and potential anti…

… aspartate (NMDA) receptor antagonist ketamine in psychiatric … ) were used to monitor key
performance parameters, such as … ), which is specifically involved in AMPA receptor trafficking. …

… First, we aim to explain the structural and functional … receptor inhibition and subsequent
AMPA receptor activation, … and-post-operative performance were found among infant groups …

… GSK-3β is an important target of the therapeutic actions of … it may have affected other kinases
that regulated by PI3K/Akt … that the antidepressant-like effects of MOs might be mediated by …